1. Wang Q, Jia S, Jiao Y, Xu L, Wang D, Chen X, Hu X, Liang H, Wen N, Zhang S, et al: SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway. Int J Med Sci2019, 16:1573-1582.
2. Jiang L, Zhao XH, Mao YL, Wang JF, Zheng HJ, You QS: Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6. J Exp Clin Cancer Res2019, 38:465.
3. Li SQ, Su N, Gong P, Zhang HB, Liu J, Wang D, Sun YP, Zhang Y, Qian F, Zhao B, et al: The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer. Sci Rep2017, 7:5918.
4. Wu H, Liu J, Yin Y, Zhang D, Xia P, Zhu G: Therapeutic Opportunities in Colorectal Cancer: Focus on Melatonin Antioncogenic Action. Biomed Res Int2019, 2019:9740568.
5. Dellas K, Reese T, Richter M, Arnold D, Dunst J: Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study. Radiat Oncol2012, 7:83.
6. Wang X, Liu J, Jiang L, Wei X, Niu C, Wang R, Zhang J, Meng D, Yao K: Bach1 Induces Endothelial Cell Apoptosis and Cell-Cycle Arrest through ROS Generation. Oxid Med Cell Longev2016, 2016:6234043.
7. Villanova L, Barbini C, Piccolo C, Boe A, De Maria R, Fiori ME: miR-1285-3p Controls Colorectal Cancer Proliferation and Escape from Apoptosis through DAPK2. Int J Mol Sci2020, 21.
8. To KK, Tong CW, Wu M, Cho WC: MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. World J Gastroenterol2018, 24:2949-2973.
9. Slattery ML, Herrick JS, Mullany LE, Samowitz WS, Sevens JR, Sakoda L, Wolff RK: The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer. Genes Chromosomes Cancer2017, 56:769-787.
10. Zeng Z, Li Y, Pan Y, Lan X, Song F, Sun J, Zhou K, Liu X, Ren X, Wang F, et al: Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun2018, 9:5395.
11. Elsherbini A, Bieberich E: Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy. Adv Cancer Res2018, 140:121-154.
12. Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D: Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. Cancer Cell2016, 30:836-848.
13. Yan W, Wu X, Zhou W, Fong MY, Cao M, Liu J, Liu X, Chen CH, Fadare O, Pizzo DP, et al: Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol2018, 20:597-609.
14. Bigagli E, Luceri C, Guasti D, Cinci L: Exosomes secreted from human colon cancer cells influence the adhesion of neighboring metastatic cells: Role of microRNA-210. Cancer Biol Ther2016, 17:1062-1069.
15. Chen X, Zhang S, Du K, Zheng N, Liu Y, Chen H, Xie G, Ma Y, Zhou Y, Zheng Y, et al: Gastric Cancer-Secreted Exosomal X26nt Increases Angiogenesis and Vascular Permeability by Targeting VE-cadherin. Cancer Sci2020.
16. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, et al: Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell2014, 25:501-515.
17. Liu T, Zhang X, Du L, Wang Y, Liu X, Tian H, Wang L, Li P, Zhao Y, Duan W, et al: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol Cancer2019, 18:43.
18. Che Y, Shi X, Shi Y, Jiang X, Ai Q, Shi Y, Gong F, Jiang W: Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3. Mol Ther Nucleic Acids2019, 18:232-244.
19. Zheng Q, Yu JJ, Li C, Li J, Wang J, Wang S: miR-224 targets BTRC and promotes cell migration and invasion in colorectal cancer. 3 Biotech2020, 10:485.
20. Mohamed ZI, Tee SF, Chow TJ, Loh SY, Yong HS, Bakar AKA, Tang PY: Functional characterization of two variants in the 3'-untranslated region (UTR) of transcription factor 4 gene and their association with schizophrenia in sib-pairs from multiplex families. Asian J Psychiatr2019, 40:76-81.
21. Li F, Zhao H, Su M, Xie W, Fang Y, Du Y, Yu Z, Hou L, Tan W: HnRNP-F regulates EMT in bladder cancer by mediating the stabilization of Snail1 mRNA by binding to its 3' UTR. EBioMedicine2019, 45:208-219.
22. Xue H, Li T, Wang P, Mo X, Zhang H, Ding S, Ma D, Lv W, Zhang J, Han W: CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer. Acta Biochim Biophys Sin (Shanghai)2019, 51:915-924.
23. Uziel O, Gutkin A, Beery E, Lahav M: [EXOSOMES AS MEDIATORS OF INTERCELLULAR COMMUNICATION: THE CANCER AND TELOMERASE CONNECTION]. Harefuah2017, 156:710-714.
24. Matsumoto Y, Kano M, Murakami K, Toyozumi T, Suito H, Takahashi M, Sekino N, Shiraishi T, Kamata T, Ryuzaki T, et al: Tumor-derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines. Cancer Sci2020, 111:4348-4358.
25. He M, Rosen J, Mangiameli D, Libutti SK: Cancer development and progression. Adv Exp Med Biol2007, 593:117-133.
26. Yuan Y, Jiang YC, Sun CK, Chen QM: Role of the tumor microenvironment in tumor progression and the clinical applications (Review). Oncol Rep2016, 35:2499-2515.
27. García-Olmo DC, Picazo MG, García-Olmo D: Transformation of non-tumor host cells during tumor progression: theories and evidence. Expert Opin Biol Ther2012, 12 Suppl 1:S199-207.
28. Lu P, Weaver VM, Werb Z: The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol2012, 196:395-406.
29. Turley SJ, Cremasco V, Astarita JL: Immunological hallmarks of stromal cells in the tumour microenvironment. Nat Rev Immunol2015, 15:669-682.
30. Kalluri R: The biology and function of exosomes in cancer. J Clin Invest2016, 126:1208-1215.
31. Kahlert C, Kalluri R: Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl)2013, 91:431-437.
32. Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y, Hou KZ, Jiang YH, Yang XH, Liu YP: Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis2009, 41:875-880.
33. Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, et al: Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Clin Cancer Res2017, 23:5311-5319.
34. Shang A, Gu C, Wang W, Wang X, Sun J, Zeng B, Chen C, Chang W, Ping Y, Ji P, et al: Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis. Mol Cancer2020, 19:117.
35. Gan BL, Zhang LJ, Gao L, Ma FC, He RQ, Chen G, Ma J, Zhong JC, Hu XH: Downregulation of miR‑224‑5p in prostate cancer and its relevant molecular mechanism via TCGA, GEO database and insilico analyses. Oncol Rep2018, 40:3171-3188.
36. Liang CQ, Fu YM, Liu ZY, Xing BR, Jin Y, Huang JL: The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance. Eur Rev Med Pharmacol Sci2017, 21:5008-5016.
37. Wei S, Peng L, Yang J, Sang H, Jin D, Li X, Chen M, Zhang W, Dang Y, Zhang G: Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer. J Exp Clin Cancer Res2020, 39:32.
38. Li T, Cheng Y, Wang P, Wang W, Hu F, Mo X, Lv H, Xu T, Han W: CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma. J Exp Clin Cancer Res2015, 34:122.